[O2] Oral Presentations 2

8:50 AM - 9:00 AM JST(11:50 PM - 12:00 AM UTC)R&D IVirology

[O2-03] Next-Generation Cross-Protective Vaccine Technology Against Dengue and Zika Based on T Cell–Mediated Immune Responses

*Meng Ling Moi^1,2 (1. Graduate School of Medicine, the University of Tokyo (Japan), 2. The UTOPIA Center, The University of Tokyo (Japan))

Password required to view

Log in

or